Cerebral venous thrombosis: Update on clinical manifestations, diagnosis and management

Annals of Indian Academy of Neurology

Volumn 11, Issue SUPPL. 5, 2008, Pages

  Leys, Didier ^a   Cordonnier, Charlotte ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Cerebral venous thrombosis; Intracranial hypertension; Stroke

Indexed keywords

ACETAZOLAMIDE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBIN III; ASPARAGINASE; COBALAMIN; D DIMER; ERYTHROPOIETIN; FIBRINOLYTIC AGENT; FOLIC ACID; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; ORAL CONTRACEPTIVE AGENT; OSMOTIC AGENT; PHYTOESTROGEN; PLACEBO; PROTEIN C; PROTEIN S; PYRIDOXINE; TAMOXIFEN; THALIDOMIDE; WARFARIN;

ACUTE DISEASE; ANTICOAGULANT THERAPY; ANTICONVULSANT THERAPY; ANTITHROMBIN DEFICIENCY; BRAIN ARTERIOVENOUS MALFORMATION; BRAIN HERNIA; BRAIN TUMOR; BRAIN VENTRICLE PERITONEUM SHUNT; CENTRAL NERVOUS SYSTEM INFECTION; CEREBRAL VENOUS SINUS THROMBOSIS; CEREBRAL VENOUS THROMBOSIS; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL PRACTICE; CLINICAL TRIAL; CONSCIOUSNESS DISORDER; CRANIECTOMY; CUSHING SYNDROME; DECOMPRESSION SURGERY; DEEP VEIN THROMBOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE PREDISPOSITION; DRUG INDICATION; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; FIBRINOLYTIC THERAPY; GERIATRIC PATIENT; GLASGOW COMA SCALE; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERVENTILATION; INFECTION; INFLAMMATORY DISEASE; INTRACRANIAL HYPERTENSION; INTRACRANIAL HYPOTENSION; LUMBAR PUNCTURE; LUNG EMBOLISM; MAGNETIC RESONANCE ANGIOGRAPHY; MASSAGE; MENINGITIS; NECK; NEOPLASM; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PAPILLEDEMA; PHLEBOGRAPHY; PRACTICE GUIDELINE; PREGNANCY; PROGNOSIS; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; PUERPERIUM; REVIEW; RISK FACTOR; SEDATION; SEIZURE; SHIATSU; STROKE; THROMBECTOMY; THROMBOPHILIA; TRAUMATIC BRAIN INJURY;

EID: 46949109360     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: None     Document Type: Review

References (72)

1. Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, et al. Prognosis of cerebral vein and dural sinus thrombosis: Results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004;35:664-70.
2. Bousser MG, Ferro JM. Cerebral venous thrombosis: an update. Lancet Neurol 2007;6:162-70.
3. Einhaupl KM, Villringer A, Meister W, Mehraein S, Garner C, Pellkofer M, et al. Heparin treatment in sinus venous thrombosis. Lancet 1991;338:597-600.
4. Stam J. The treatment of cerebral venous sinus thrombosis. Adv Neurol 2003;92:233-40.
5. Breteau G, Mounier-Vehier F, Godefroy O, Gauvrit JY, Mackowiak-Cordoliani MA, Girot M, et al. Cerebral venous thrombosis 3-year clinical outcome in 55 consecutive patients. J Neurol 2003;250:29-35.
6. Ferro J, Lopes M, Rosas M, Fontes J; VENOPORT Investigators. Delay in hospital admission of patients with cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 2005;19:152-6.
7. Cumurciuc R, Crassard I, Sarov M, Valade D, Bousser MG. Headache as the only neurological sign of cerebral venous thrombosis: A series of 17 cases. J Neurol Neurosurg Psychiatry 2005;76:1084-7.
8. Diener HC. Cerebral venous thrombosis - headache is enough. J Neurol Neurosurg Psychiatry 2005;76:1043.
9. Ferro JM, Correia M, Rosas MJ, Pinto AN, Neves G; Cerebral Venous Thrombosis Portuguese Collaborative Study Group[Venoport]. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis 2003;15:78-83.
10. Ameri A, Bousser MG. Cerebral venous thrombosis. Neurol Clin 1992;10:87-111.
11. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 2005;352:1791-8.
12. Oppenheim C, Domigo V, Gauvrit JY, Lamy C, Mackowiak-Cordoliani MA, Pruvo JP, et al. Subarachnoid hemorrhage as the initial presentation of dural sinus thrombosis. AJNR Am J Neuroradiol 2005;26:614-7.
13. van den Bergh WM, van der Schaaf I, van Gijn J. The spectrum of presentations of venous infarction caused by deep cerebral vein thrombosis. Neurology 2005;65:192-6.
14. Ferro JM, Canhao P, Bousser MG, Stam J, Barinagarrementeria F; ISCVT Investigators. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 2005;36:1927-32.
15. Bousser MG. Cerebral venous thrombosis: Diagnosis and management. J Neurol 2000;247:252-8.
16. Masuhr F, Mehraein S, Einhaupl K. Cerebral venous and sinus thrombosis. J Neurol 2004;251:11-23.
17. Ahn TB, Roh JK. A case of cortical vein thrombosis with the cord sign. Arch Neurol 2003;60:1314-6.
18. Duncan IC, Fourie PA. Imaging of cerebral isolated cortical vein thrombosis. AJR Am J Roentgenol 2005;184:1317-9.
19. Urban PP, Muller-Forell W. Clinical and neuroradiological spectrum of isolated cortical vein thrombosis. J Neurol 2005;252:1476-81.
20. Ferro JM, Morgado C, Sousa R, Canhao P. Interobserver agreement in the magnetic resonance location of cerebral vein and dural sinus thrombosis. Eur J Neurol 2007;14:353-6.
21. Selim M, Fink J, Linfante I, Kumar S, Schlaug G, Caplan LR. Diagnosis of cerebral venous thrombosis with echo-planar T2*-weighted magnetic resonance imaging. Arch Neurol 2002;59:1021-6.
22. Cakmak S, Hermier M, Montavont A, Derex L, Mauguière F, Trouillas P, et al. T2*-weighted MRI in cortical venous thrombosis. Neurology 2004;63:1698.
23. Idbaih A, Boukobza M, Crassard I, Porcher R, Bousser MG, Chabriat H. MRI of clot in cerebral venous thrombosis: High diagnostic value of susceptibility-weighted images. Stroke 2006;37:991-5.
24. Lovblad KO, Bassetti C, Schneider J, Guzman R, El-Koussy M, Remonda L, et al. Diffusion-weighted MR in cerebral venous thrombosis. Cerebrovasc Dis 2001;11:169-76.
25. Chu K, Kang DW, Yoon BW, Roh JK. Diffusion-weighted magnetic resonance in cerebral venous thrombosis. Arch Neurol 2001;58:1569-76.
26. Favrole P, Guichard JP, Crassard I, Bousser MG, Chabriat H. Diffusion-weighted imaging of intravascular clots in cerebral venous thrombosis. Stroke 2004;35:99-103.
27. Corvol JC, Oppenheim C, Manai R, Logak M, Dormont D, Samson Y, et al. Diffusion-weighted magnetic resonance imaging in a case of cerebral venous thrombosis. Stroke 1998;29:2649-52.
28. Keller E, Flacke S, Urbach H, Schild HH. Diffusion- and perfusion-weighted magnetic resonance imaging in deep cerebral venous thrombosis. Stroke 1999;30:1144-6.
29. Manzione J, Newman GC, Shapiro A, Santo-Ocampo R. Diffusion- and perfusion-weighted MR imaging of dural sinus thrombosis. AJNR Am J Neuroradiol 2000;21:68-73.
30. Ducreux D, Oppenheim C, Vandamme X, Dormont D, Samson Y, Rancurel G, et al. Diffusion-weighted imaging patterns of brain damage associated with cerebral venous thrombosis. AJNR Am J Neuroradiol 2001;22:261-8.
31. Doege CA, Tavakolian R, Kerskens CM, Romero BI, Lehmann R, Einhäupl KM, et al. Perfusion and diffusion magnetic resonance imaging in human cerebral venous thrombosis. J Neurol 2001;248:564-71.
32. Forbes KP, Pipe JG, Heiserman JE. Evidence for cytotoxic edema in the pathogenesis of cerebral venous infarction. AJNR Am J Neuroradiol 2001;22:450-5.
33. Mullins ME, Grant PE, Wang B, Gonzalez RG, Schaefer PW. Parenchymal abnormalities associated with cerebral venous sinus thrombosis: Assessment with diffusion-weighted MR imaging. AJNR Am J Neuroradiol 2004;25:1666-75.
34. Talbot K, Wright M, Keeling D. Normal d-dimer levels do not exclude the diagnosis of cerebral venous sinus thrombosis. J Neurol 2002;249:1603-4.
35. Lalive PH, de Moerloose P, Lovblad K, Sarasin FP, Mermillod B, Sztajzel R. Is measurement of D-dimer useful in the diagnosis of cerebral venous thrombosis? Neurology 2003;61:1057-60.
36. Tardy B, Tardy-Poncet B, Viallon A, Piot M, Garnier P, Mohamedi R, et al. D-dimer levels in patients with suspected acute cerebral venous thrombosis. Am J Med 2002;113:238-41.
37. Kosinski CM, Mull M, Schwarz M, Koch B, Biniek R, Schläfer J, et al. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis? Stroke 2004;35:2820-5.
38. Crassard I, Soria C, Tzourio C, Woimant F, Drouet L, Ducros A, et al. A negative D-dimer assay does not rule out cerebral venous thrombosis: A series of seventy-three patients. Stroke 2005;36:1716-9.
39. Bugnicourt JM, Roussel B, Tramier B, Lamy C, Godefroy O. Cerebral venous thrombosis and plasma concentrations of factor VIII and von Willebrand factor: A case control study. J Neurol Neurosurg Psychiatry 2007;78:699-701.
40. Le Cam-Duchez V, Bagan-Triquenot A, Menard JF, Mihout B, Borg JY. Association of the protein C promoter CG haplotype and the factor II G20210A mutation is a risk factor for cerebral venous thrombosis. Blood Coagul Fibrinolysis 2005;16:495-500.
41. Martinelli I, Battaglioli T, Pedotti P, Cattaneo M, Mannucci PM. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 2003;102:1363-6.
42. Lichy C, Dong-Si T, Reuner K, Genius J, Rickmann H, Hampe T, et al. Risk of cerebral venous thrombosis and novel gene polymorphisms of the coagulation and p brinolytic systems. J Neurol 2006;253:316-20.
43. Cantu C, Alonso E, Jara A, Martínez L, Ríos C, Fernández Mde L, et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 2004;35:1790-4.
44. Ventura P, Cobelli M, Marietta M, Panini R, Rosa MC, Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis 2004;17:153-9.
45. Berroir S, Grabli D, Heran F, Bakouche P, Bousser MG. Cerebral sinus venous thrombosis in two patients with spontaneous intracranial hypotension. Cerebrovasc Dis 2004;17:9-12.
46. Lenz RA, Saver J. Venous sinus thrombosis in a patient taking thalidomide. Cerebrovasc Dis 2004;18:175-7.
47. Yoshimura S, Ago T, Kitazono T, Yonekura T, Kumai Y, Kuroda J, et al. Cerebral sinus thrombosis in a patient with Cushing's syndrome. J Neurol Neurosurg Psychiatry 2005;76:1182-3.
48. Masjuan J, Pardo J, Callejo JM, Andres MT, Alvarez-Cermeno JC. Tamoxifen: A new risk factor for cerebral sinus thrombosis. Neurology 2004;62:334-5.
49. Finelli PF, Carley MD. Cerebral venous thrombosis associated with epoetin alfa therapy. Arch Neurol 2000;57:260-2.
50. Basnyat B, Cumbo TA, Edelman R. Acute medical problems in the Himalayas outside the setting of altitude sickness. High Alt Med Biol 2000;1:167-74.
51. Guimaraes J, Azevedo E. Phytoestrogens as a risk factor for cerebral sinus thrombosis. Cerebrovasc Dis 2005;20:137-8.
52. Wada Y, Yanagihara C, Nishimura Y. Internal jugular vein thrombosis associated with shiatsu massage of the neck. J Neurol Neurosurg Psychiatry 2005;76:142-3.
53. Rondepierre P, Hamon M, Leys D, Leclerc X, Mounier-Vehier F, Godefroy O, et al. Cerebral venous thromboses: study of the course. Rev Neurol (Paris) 1995;151:100-4.
54. Preter M, Tzourio C, Ameri A, Bousser MG. Long-term prognosis in cerebral venous thrombosis: Follow-up of 77 patients. Stroke 1996;27:243-6.
55. de Bruijn SF, de Haan RJ, Stam J. Clinical features and prognostic factors of cerebral venous sinus thrombosis in a prospective series of 59 patients. J Neurol Neurosurg Psychiatry 2001;70:105-8.
56. Ferro JM, Lopes MG, Rosas MJ, Ferro MA, Fontes J; Cerebral Venous Thrombosis Portugese Collaborative Study Group. Long-term prognosis of cerebral vein and dural sinus thrombosis: Results of the VENOPORT study. Cerebrovasc Dis 2002;13:272-8.
57. Cakmak S, Derex L, Berruyer M, Nighoghossian N, Philippeau F, Adeleine P, et al. Cerebral venous thrombosis: Clinical outcome and systematic screening of prothrombotic factors. Neurology 2003;60:1175-8.
58. Canhao P, Ferro JM, Lindgren AG, Bousser MG, Stam J, Barinagarrementeria F, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005;36:1720-5.
59. Diaz JM, Schiffman JS, Urban ES, Maccario M. Superior sagittal sinus thrombosis and pulmonary embolism: A syndrome rediscovered. Acta Neurol Scand 1992;86:390-6.
60. Girot M, Ferro JM, Canhao P, Stam J, Bousser MG, Barinagarrementeria F, et al. Predictors of outcome in patients with cerebral venous thrombosis and intracerebral hemorrhage. Stroke 2007;38:337-42.
61. Einhaupl K, Bousser MG, de Bruijn SF, Ferro JM, Martinelli I, Masuhr F, et al. EFNS guideline on the treatment of cerebral venous and sinus thrombosis. Eur J Neurol 2006;13:553-9.
62. de Bruijn SF, Stam J. Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis. Stroke 1999;30:484-8.
63. Nagaraja D, Rao B, Taly A, Subhash M. Randomized controlled trial of heparin in puerperal cerebral venous/sinus thrombosis. NIMHANS J 1995;13:111-5.
64. Stam J, De Bruijn S, DeVeber G. Anticoagulation for cerebral sinus thrombosis. Cochrane Database Syst Rev 2002;4:CD002005.
65. Canhao P, Falcao F, Ferro JM. Thrombolytics for cerebral sinus thrombosis: A systematic review. Cerebrovasc Dis 2003;15:159-66.
66. Petzold A, Smith M. High intracranial pressure, brain herniation and death in cerebral venous thrombosis. Stroke 2006;37:331-2.
67. Masuhr F, Busch M, Amberger N, Ortwein H, Weih M, Neumann K, et al. Risk and predictors of early epileptic seizures in acute cerebral venous and sinus thrombosis. Eur J Neurol 2006;13:852-6.
68. Purvin VA, Trobe JD, Kosmorsky G. Neuro-ophthalmic features of cerebral venous obstruction. Arch Neurol 1995;52:880-5.
69. de Bruijn SF, Budde M, Teunisse S, de Haan RJ, Stam J. Long-term outcome of cognition and functional health after cerebral venous sinus thrombosis. Neurology 2000;54:1687-9.
70. Srinivasan K. Cerebral venous and arterial thrombosis in pregnancy and puerperium: A study of 135 patients. Angiology 1983;34:731-6.
71. Lamy C, Hamon JB, Coste J, Mas JL. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies: French Study Group on Stroke in Pregnancy. Neurology 2000;55:269-74.
72. Mehraein S, Ortwein H, Busch M, Weih M, Einhaupl K, Masuhr F. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry 2003;74:814-6.